Related references
Note: Only part of the references are listed.Impact of short-chain fatty acid supplementation on gut inflammation and microbiota composition in a murine colitis model
Jae Gon Lee et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2022)
Butyrate, a typical product of gut microbiome, affects function of the AhR gene, being a possible agent of crosstalk between gut microbiome, and hepatic drug metabolism
Lenka Jourova et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2022)
Gut microbiota in human metabolic health and disease
Yong Fan et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Gut microbiome affects the metabolism of metronidazole in mice through regulation of hepatic cytochromes P450 expression
Nina Zemanova et al.
PLOS ONE (2021)
Normal variation of the gut microbiota affects hepatic cytochrome P450 activity in mice
Masao Togao et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2021)
The microbiome and inflammatory bowel disease
Kerri L. Glassner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Hepatic and intestinal biotransformation gene expression and drug disposition in a dextran sulfate sodium-induced colitis mouse model
Xiaoyu Fan et al.
ACTA PHARMACEUTICA SINICA B (2020)
Nutrition, IBD and Gut Microbiota: A Review
Maria Chiara Mentella et al.
NUTRIENTS (2020)
Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis
Anja Baumann et al.
NUTRIENTS (2020)
The role of the microbiome and psychosocial stress in the expression and activity of drug metabolizing enzymes in mice
Nina Zemanova et al.
SCIENTIFIC REPORTS (2020)
Impact of Microbiome on Hepatic Metabolizing Enzymes and Transporters in Mice during Pregnancy
Lyrialle W. Han et al.
DRUG METABOLISM AND DISPOSITION (2020)
The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)-A Critical Review
Dominika Jakubczyk et al.
NUTRIENTS (2020)
Gut Microbiome Alters the Activity of Liver Cytochromes P450 in Mice With Sex-Dependent Differences
Lenka Jourova et al.
FRONTIERS IN PHARMACOLOGY (2020)
Pathophysiology of Inflammatory Bowel Diseases
John T. Chang
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Presence or Absence of Microbiome Modulates the Response of Mice Organism to Administered Drug Nabumetone
Lenka Jourova et al.
PHYSIOLOGICAL RESEARCH (2020)
Gut microbiota metabolizes nabumetone in vitro: Consequences for its bioavailability in vivo in the rodents with altered gut microbiome
Lenka Jourova et al.
XENOBIOTICA (2019)
Effects of oral butyrate supplementation on inflammatory potential of circulating peripheral blood mononuclear cells in healthy and obese males
Maartje C. P. Cleophas et al.
SCIENTIFIC REPORTS (2019)
Gut Microbiome: Profound Implications for Diet and Disease
Ronald D. Hills et al.
NUTRIENTS (2019)
Biologics beyond Anti-TNF Agents for Ulcerative Colitis - Efficacy, Safety, and Cost?
Richard J. Farrell
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites
Yufang Ding et al.
PHARMACOLOGICAL RESEARCH (2019)
Gut microbiome structure and metabolic activity in inflammatory bowel disease
Eric A. Franzosa et al.
NATURE MICROBIOLOGY (2019)
Determinants of Reduced Genetic Capacity for Butyrate Synthesis by the Gut Microbiome in Crohn's Disease and Ulcerative Colitis
Emilio J. Laserna-Mendieta et al.
JOURNAL OF CROHNS & COLITIS (2018)
short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders
P. A. Gill et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Primary Non-Response to Tumor Necrosis Factor Antagonists is Associated with Inferior Response to Second-line Biologics in Patients with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis
Siddharth Singh et al.
JOURNAL OF CROHNS & COLITIS (2018)
In vivo evaluation of effect of anthocyanin-rich wheat on rat liver microsomal drug-metabolizing cytochromes P450 and on biochemical and antioxidant parameters in rats
Jiri Prokop et al.
FOOD AND CHEMICAL TOXICOLOGY (2018)
Impact of Diet-Modulated Butyrate Production on Intestinal Barrier Function and Inflammation
Knud Erik Bach Knudsen et al.
NUTRIENTS (2018)
Interleukin-15 promotes intestinal dysbiosis with butyrate deficiency associated with increased susceptibility to colitis
Marlies Meisel et al.
ISME JOURNAL (2017)
Colonization by non-pathogenic bacteria alters mRNA expression of cytochromes P450 in originally germ-free mice
L. Jourova et al.
FOLIA MICROBIOLOGICA (2017)
Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier
Da Zhou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway
Hui Yan et al.
PLOS ONE (2017)
Human gut microbiota plays a role in the metabolism of drugs
Lenka Jourova et al.
BIOMEDICAL PAPERS-OLOMOUC (2016)
Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition
Martin Schwarzer et al.
SCIENCE (2016)
Microbial metabolite butyrate facilitates M2 macrophage polarization and function
Jian Ji et al.
SCIENTIFIC REPORTS (2016)
Regulation of Hepatic Drug-Metabolizing Enzymes in Germ-Free Mice by Conventionalization and Probiotics
Felcy Pavithra Selwyn et al.
DRUG METABOLISM AND DISPOSITION (2016)
Sodium Butyrate Promotes Reassembly of Tight Junctions in Caco-2 Monolayers Involving Inhibition of MLCK/MLC2 Pathway and Phosphorylation of PKCβ2
Wei Miao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model
Rebeca Martin et al.
BMC MICROBIOLOGY (2015)
RNA-Seq Quantification of Hepatic Drug Processing Genes in Germ-Free Mice
Felcy Pavithra Selwyn et al.
DRUG METABOLISM AND DISPOSITION (2015)
Hepatic early inflammation induces downregulation of hepatic cytochrome P450 expression and metabolic activity in the dextran sulfate sodium-induced murine colitis
Yoshiki Kusunoki et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Downregulation of CYP3A and P-Glycoprotein in the Secondary Inflammatory Response of Mice With Dextran Sulfate Sodium Induced Colitis and Its Contribution to Cyclosporine A Blood Concentrations
Shoji Kawauchi et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2014)
The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition
Pamela V. Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Effects of Sodium Butyrate and Its Synthetic Amide Derivative on Liver Inflammation and Glucose Tolerance in an Animal Model of Steatosis Induced by High Fat Diet
Giuseppina Mattace Raso et al.
PLOS ONE (2013)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Central role of the gut epithelial barrier in the pathogenes of chronic intestinal inflammation: lessons learned from animal models and human genetics
Luca Pastorelli et al.
FRONTIERS IN IMMUNOLOGY (2013)
Expression Variability of Absorption, Distribution, Metabolism, Excretion-Related MicroRNAs in Human Liver: Influence of Nongenetic Factors and Association with Gene Expressions
Jessica K. Rieger et al.
DRUG METABOLISM AND DISPOSITION (2013)
Protective effect of Clostridium tyrobutyricum in acute dextran sodium sulphate-induced colitis: differential regulation of tumour necrosis factor-α and interleukin-18 in BALB/c and severe combined immunodeficiency mice
T. Hudcovic et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway
Vicky De Preter et al.
INFLAMMATORY BOWEL DISEASES (2012)
Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis
Erica L. M. Vieira et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH
Erwin Gäbele et al.
JOURNAL OF HEPATOLOGY (2011)
MicroRNAs from biology to future pharmacotherapy: Regulation of cytochrome P450s and nuclear receptors
Miki Nakajima et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Potential beneficial effects of butyrate in intestinal and extrainitestinal diseases
Roberto Berni Canani et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission
Henrike M. Hamer et al.
CLINICAL NUTRITION (2010)
Inflammation: Planning for a Source of Pharmacokinetic/Pharmacodynamic Variability in Translational Studies
V. D. Schmith et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Epithelial Tight Junctions in Intestinal Inflammation
Joerg D. Schulzke et al.
MOLECULAR STRUCTURE AND FUNCTION OF THE TIGHT JUNCTION: FROM BASIC MECHANISMS TO CLINICAL MANIFESTATIONS (2009)
Butyrate Enhances the Intestinal Barrier by Facilitating Tight Junction Assembly via Activation of AMP-Activated Protein Kinase in Caco-2 Cell Monolayers
Luying Peng et al.
JOURNAL OF NUTRITION (2009)
Sexually dimorphic regulation and induction of P450s by the constitutive androstane receptor (CAR)
J. P. Hernandez et al.
TOXICOLOGY (2009)
The short chain fatty acid, butyrate, stimulates MUC2 mucin production in the human colon cancer cell line, LS174T
Hajime Hatayama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Growth hormone regulation of sex-dependent liver gene expression
David J. Waxman et al.
MOLECULAR ENDOCRINOLOGY (2006)
Codependence of growth hormone-responsive, sexually dimorphic hepatic gene expression on signal transducer and activator of transcription 5b and hepatic nuclear factor 4α
MG Holloway et al.
MOLECULAR ENDOCRINOLOGY (2006)
Oral butyrate for mildly to moderately active Crohn's disease
A Di Sabatino et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Interaction of mucosal microbiota with the innate immune system
H Tlaskalova-Hogenova et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2005)
Increasing fecal butyrate in ulcerative colitis patients by diet:: Controlled pilot study
C Hallert et al.
INFLAMMATORY BOWEL DISEASES (2003)
Butyrate inhibits NF-κB activation in lamina propria macrophages of patients with ulcerative colitis
H Lührs et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Pharmacokinetics of cyclosporin microemulsion in patients with inflammatory bowel disease
M Latteri et al.
CLINICAL PHARMACOKINETICS (2001)
Share Paper
